Dashboard
Manage Tickers

VTRVentas, Inc.

NYSE ventasreit.com


$ 46.80 $ 0.57 (1.23 %)    

Friday, 03-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 46.79
$ 46.80
$ 0.00 x 0
$ 0.00 x 0
$ 45.94 - $ 46.88
$ 38.58 - $ 50.08
3,110,986
na
18.94B
$ 1.61
nm
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 07-26-2019 06-30-2019 10-Q
21 04-29-2019 03-31-2019 10-Q
22 02-08-2019 12-31-2018 10-K
23 10-26-2018 09-30-2018 10-Q
24 07-27-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-09-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-14-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-29-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 10-26-2015 09-30-2015 10-Q
36 07-27-2015 06-30-2015 10-Q
37 04-24-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 10-24-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ventas-reiterates-guidance
Ventas Reiterates Guidance
05/01/2024 20:15:05

Full Year 2024 Guidance as of May 1, 20241Net Income and FFO Attributable to Common Stockholders2(In millions, except per share...

ventas-q1-2024-ffo-078-beats-074-estimate-sales-119b-beat-116b-estimate
Ventas Q1 2024 FFO $0.78 Beats $0.74 Estim...
05/01/2024 20:11:09

Ventas (NYSE:VTR) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.74 by 5.41 per...

these-3-real-estate-stocks-with-over-4-dividend-yields-are-recommended-by-wall-streets-most-accurate-analysts
These 3 Real Estate Stocks With Over 4% Di...
05/01/2024 12:58:42

vtr---analyzing-ventass-short-interest
(VTR) - Analyzing Ventas's Short Interest
03/29/2024 15:30:19

cracking-the-code-understanding-analyst-reviews-for-ventas
Cracking The Code: Understanding Analyst R...
03/18/2024 14:00:33

evercore-isi-group-upgrades-ventas-to-outperform-announces-50-price-target
Evercore ISI Group Upgrades Ventas to Outp...
03/18/2024 10:00:52

Evercore ISI Group analyst Steve Sakwa upgrades Ventas (NYSE:VTR) from In-Line to Outperform and announces $50 price target.

ventas-enters-into-cooperation-agreement-with-land--buildings-terms-not-disclosed
Ventas Enters Into Cooperation Agreement W...
03/04/2024 13:19:57

key-takeaways-from-ventas-analyst-ratings
Key Takeaways From Ventas Analyst Ratings
02/26/2024 12:00:48

wells-fargo-downgrades-ventas-to-equal-weight-announces-46-price-target
Wells Fargo Downgrades Ventas to Equal-Wei...
02/26/2024 11:44:27

Wells Fargo analyst Connor Siversky downgrades Ventas (NYSE:VTR) from Overweight to Equal-Weight and announces $46 price tar...

wall-streets-most-accurate-analysts-views-on-3-real-estate-stocks-with-over-4-dividend-yields
Wall Street's Most Accurate Analysts' View...
02/21/2024 13:15:12

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

ventas-expects-fy24-normalized-ffo-per-share-of-307-318-est-321
Ventas Expects FY24 Normalized FFO Per Sha...
02/14/2024 21:20:57

ventas-q4-normalized-ffo-per-share-076-beats-075-estimate-sales-116b-beat-115b-estimate
Ventas Q4 Normalized FFO Per Share $0.76 B...
02/14/2024 21:17:13

Ventas (NYSE:VTR) reported quarterly Normalized FFO of $0.76 per share which beat the analyst consensus estimate of $0.75 by 1....

earnings-scheduled-for-february-14-2024
Earnings Scheduled For February 14, 2024
02/14/2024 09:48:44

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

deutsche-bank-initiates-coverage-on-ventas-with-buy-rating-announces-price-target-of-60
Deutsche Bank Initiates Coverage On Ventas...
01/30/2024 12:07:25

Deutsche Bank analyst Omotayo Okusanya initiates coverage on Ventas (NYSE:VTR) with a Buy rating and announces Price Target ...

forecasting-the-future-4-analyst-projections-for-ventas
Forecasting The Future: 4 Analyst Projecti...
01/16/2024 20:00:21

b-of-a-securities-upgrades-ventas-to-buy-raises-price-target-to-53
B of A Securities Upgrades Ventas to Buy, ...
01/16/2024 17:16:34

B of A Securities analyst Joshua Dennerlein upgrades Ventas (NYSE:VTR) from Neutral to Buy and raises the price target from ...

ventas-confirms-issues-statement-regarding-three-director-nominations-by-land--buildings-investment-management
Ventas Confirms Issues Statement Regarding...
01/11/2024 13:53:05

No Shareholder Action Required at This TimeThe Ventas Board of Directors and management team are committed to acting in the bes...

mizuho-maintains-buy-on-ventas-raises-price-target-to-56
Mizuho Maintains Buy on Ventas, Raises Pri...
01/03/2024 15:40:09

Mizuho analyst Vikram Malhorta maintains Ventas (NYSE:VTR) with a Buy and raises the price target from $53 to $56.

wells-fargo-maintains-overweight-on-ventas-lowers-price-target-to-47
Wells Fargo Maintains Overweight on Ventas...
11/13/2023 15:12:00

Wells Fargo analyst Connor Siversky maintains Ventas (NYSE:VTR) with a Overweight and lowers the price target from $49 to $47.

jim-cramer-asks-why-the-worlds-largest-healthcare-products-company-has-an-ill-advised-strategy
Jim Cramer Asks Why The World's Largest He...
11/08/2023 13:35:41

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Clorox Company’s (NYSE: CLX) recent quarter was "ok.&#...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION